Correlation Between UPS CDR and NervGen Pharma
Can any of the company-specific risk be diversified away by investing in both UPS CDR and NervGen Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining UPS CDR and NervGen Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between UPS CDR and NervGen Pharma Corp, you can compare the effects of market volatilities on UPS CDR and NervGen Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in UPS CDR with a short position of NervGen Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of UPS CDR and NervGen Pharma.
Diversification Opportunities for UPS CDR and NervGen Pharma
0.08 | Correlation Coefficient |
Significant diversification
The 3 months correlation between UPS and NervGen is 0.08. Overlapping area represents the amount of risk that can be diversified away by holding UPS CDR and NervGen Pharma Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NervGen Pharma Corp and UPS CDR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on UPS CDR are associated (or correlated) with NervGen Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NervGen Pharma Corp has no effect on the direction of UPS CDR i.e., UPS CDR and NervGen Pharma go up and down completely randomly.
Pair Corralation between UPS CDR and NervGen Pharma
Assuming the 90 days trading horizon UPS CDR is expected to generate 0.99 times more return on investment than NervGen Pharma. However, UPS CDR is 1.01 times less risky than NervGen Pharma. It trades about -0.04 of its potential returns per unit of risk. NervGen Pharma Corp is currently generating about -0.05 per unit of risk. If you would invest 1,622 in UPS CDR on December 21, 2024 and sell it today you would lose (105.00) from holding UPS CDR or give up 6.47% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
UPS CDR vs. NervGen Pharma Corp
Performance |
Timeline |
UPS CDR |
NervGen Pharma Corp |
UPS CDR and NervGen Pharma Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with UPS CDR and NervGen Pharma
The main advantage of trading using opposite UPS CDR and NervGen Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if UPS CDR position performs unexpectedly, NervGen Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NervGen Pharma will offset losses from the drop in NervGen Pharma's long position.UPS CDR vs. Primaris Retail RE | UPS CDR vs. Atrium Mortgage Investment | UPS CDR vs. TGS Esports | UPS CDR vs. Verizon Communications CDR |
NervGen Pharma vs. NervGen Pharma Corp | NervGen Pharma vs. Medicenna Therapeutics Corp | NervGen Pharma vs. Arch Biopartners | NervGen Pharma vs. Sirona Biochem Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Watchlist Optimization module to optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm.
Other Complementary Tools
Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |